{"filing":{"accession_number":"0001104659-26-075442","cik":"0001455365","ticker":"CGTX","company_name":"COGNITION THERAPEUTICS INC","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"tm2618236d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465926075442/tm2618236d1_8k.htm"},"events":[{"id":11712,"run_id":10295,"accession_number":"0001104659-26-075442","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder voting results from Cognition Therapeutics' Annual Meeting of Stockholders held on June 17, 2026. The filing reports final vote tallies for two proposals: election of Class II directors (Aaron Fletcher, Ph.D. and Lisa Ricciardi) and ratification of Ernst \u0026 Young LLP as independent auditors. The detailed voting counts (For, Against, Withheld, Abstentions, Broker Non-Votes) are the hallmark of Item 5.07 shareholder vote results disclosures, which are material to investors as they confirm governance outcomes and auditor appointment.","company_name":"COGNITION THERAPEUTICS INC","ticker":"CGTX","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":8368,"accession_number":"0001104659-26-075442","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Cognition Therapeutics' Annual Meeting of Stockholders held on June 17, 2026. The filing reports final vote tallies for two proposals: election of Class II directors (Aaron Fletcher, Ph.D. and Lisa Ricciardi) and ratification of Ernst \u0026 Young LLP as independent auditors. The detailed voting counts (For, Against, Withheld, Abstentions, Broker Non-Votes) are the hallmark of Item 5.07 shareholder vote results disclosures, which are material to investors as they confirm governance outcomes and auditor appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T12:06:06.617840+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8368,"accession_number":"0001104659-26-075442","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Cognition Therapeutics' Annual Meeting of Stockholders held on June 17, 2026. The filing reports final vote tallies for two proposals: election of Class II directors (Aaron Fletcher, Ph.D. and Lisa Ricciardi) and ratification of Ernst \u0026 Young LLP as independent auditors. The detailed voting counts (For, Against, Withheld, Abstentions, Broker Non-Votes) are the hallmark of Item 5.07 shareholder vote results disclosures, which are material to investors as they confirm governance outcomes and auditor appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T12:06:06.617840+00:00","company_name":"COGNITION THERAPEUTICS INC","ticker":"CGTX","filing_date":"2026-06-18"}]}